Fertility and ovarian function in high-dose estrogen-treated tall women

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 4, 2011, Pages 1098-1105

  Hendriks, A E J ^a   Laven, J S E ^b   Valkenburg, O ^b   Fong, S Lie ^b   Fauser, B C J M ^d   De Ridder, M A J ^b   De Jong, F H ^c   Visser, J A ^c   Van Ginneken, A M ^b   Boot, A M ^e   Drop, S L S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Internal Medicine   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; GESTAGEN; MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FEMALE FERTILITY; FEMALE SUBFERTILITY; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPERGONADOTROPISM; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY FUNCTION; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TALL STATURE; TREATMENT DURATION;

ADOLESCENT; ADULT; BODY HEIGHT; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; FERTILITY; GROWTH DISORDERS; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; OVARY; PREGNANCY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79953867318     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2244     Document Type: Article

References (30)

1. Venn A, Bruinsma F, Werther G, Pyett P, Baird D, Jones P, Rayner J, Lumley J 2004 Oestrogen treatment to reduce the adult height of tall girls: Long-term effects on fertility. Lancet 364:1513-1518 (Pubitemid 39410417)
2. de Waal WJ, Torn M, de Muinck Keizer-Schrama SM, Aarsen RS, Drop SL 1995 Long term sequelae of sex steroid treatment in the management of constitutionally tall stature. Arch Dis Child 73:311-315
3. Normann EK, Trygstad O, Larsen S, Dahl-JørgensenK1991 Height reduction in 539 tall girls treated with three different dosages of ethinyloestradiol. Arch Dis Child 66:1275-1278
4. FredriksAM,van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM 2000 Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 47:316-323 (Pubitemid 30127036)
5. Drop SL, de Waal WJ, De Muinck Keizer-Schrama SM 1998 Sex steroid treatment of constitutionally tall stature. Endocr Rev 19: 540-558 (Pubitemid 28467710)
6. Wettenhall HN, Cahill C, Roche AF 1975 Tall girls: A survey of 15 years of management and treatment. J Pediatr 86:602-610
7. de Waal WJ, Greyn-Fokker MH, Stijnen T, van Gurp EA, Toolens AM, de Munick Keizer-Schrama SM, Aarsen RS, Drop SL 1996 Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children. J Clin Endocrinol Metab 81:1206-1216 (Pubitemid 26083994)
8. Evers JL 2002 Female subfertility. Lancet 360:151-159 (Pubitemid 34786208)
9. Bayley N, Pinneau SR 1952 Tables for predicting adult height from skeletal age: Revised for use with the Greulich-Pyle hand standards. J Pediatr 40:423-441
10. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC 2002 Antimullerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril 77:357-362 (Pubitemid 34083560)
11. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Fauser BJ, Themmen AP, te Velde ER 2005 Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril 83:979-987
12. van Heusden AM, Fauser BC 1999 Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception 59:237-243 (Pubitemid 29361479)
13. van Santbrink EJ, Hop WC, Fauser BC 1997 Classification of normogonadotropic infertility: Polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 67:452-458 (Pubitemid 27085957)
14. Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, teJong FH, teVelde ER 2003 The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18:700-706 (Pubitemid 36426945)
15. Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born BM, de Jong FH, Groome NP, Themmen AP, Visser JA 2006 Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 147:3228-3234 (Pubitemid 43901114)
16. Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A, Dennerstein L 1999 Prospectively measured levels of serum follicle- stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84:4025-4030 (Pubitemid 30644189)
17. ESHRE Capri Workshop 1995 Anovulatory infertility. Hum Reprod 10:1549-1553
18. Rowe PJ, Comhaire FA, Hargreave TB, Mellows HJ 1997 WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge, UK: Cambridge University Press
19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
20. Baird DT, Collins J, Egozcue J, Evers LH, Gianaroli L, Leridon H, Sunde A, Templeton A, Van Steirteghem A, Cohen J, Crosignani PG, Devroey P, Diedrich K, Fauser BC, Fraser L, Glasier A, Liebaers I, Mautone G, Penney G, Tarlatzis B; ESHRE Capri Workshop 2005 Fertility and ageing. Hum Reprod Update 11:261-276 (Pubitemid 40668111)
21. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N 2001 Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76:874-878 (Pubitemid 33031310)
22. Evers JL, Slaats P, Land JA, Dumoulin JC, Dunselman GA 1998 Elevated levels of basal estradiol-17β predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril 69:1010-1014 (Pubitemid 28274888)
23. Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booij MJ, Hoek A, BeerendonkCC,Laven JS, Goverde AJ, Broekmans FJ,Themmen AP, de Jong FH, Fauser BC 2009 Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 94:786-792
24. Bracken MB, Hellenbrand KG, HolfordTR1990 Conception delay after oral contraceptive use: The effect of estrogen dose. Fertil Steril 53:21-27 (Pubitemid 20041310)
25. Farrow A, Hull MG, Northstone K, Taylor H, Ford WC, Golding J 2002 Prolonged use of oral contraception before a planned pregnancy is associated with a decreased risk of delayed conception. Hum Reprod 17:2754-2761 (Pubitemid 35174132)
26. Visser JA, de Jong FH, Laven JS,ThemmenAP2006 Anti-Mullerian hormone: A new marker for ovarian function. Reproduction 131:1-9 (Pubitemid 43230697)
27. Fauser BC, Van HeusdenAM1997 Manipulation of human ovarian function: Physiological concepts and clinical consequences. Endocr Rev 18:71-106 (Pubitemid 27076456)
28. Laven JS, Mulders AG, Visser JA,ThemmenAP,DeJong FH, Fauser BC 2004 Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89:318-323 (Pubitemid 38183899)
29. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 2001 Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142:4891-4899 (Pubitemid 33022365)
30. Norman RJ, Dewailly D, Legro RS, Hickey TE 2007 Polycystic ovary syndrome. Lancet 370:685-697 (Pubitemid 47285318)